Endpoints News 2026년 2월 25일 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy
Endpoints News 2026년 2월 24일 Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market
Endpoints News 2026년 2월 24일 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push